Induction of UDP-Glucuronosyltransferase 2B15 Gene Expression by the Major Active Metabolites of Tamoxifen, 4-Hydroxytamoxifen and Endoxifen, in Breast Cancer Cells

Drug Metabolism and Disposition - United States
doi 10.1124/dmd.114.062935
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

The Active Tamoxifen Metabolite Endoxifen (4OHNDtam) Strongly Down-Regulates Cytokeratin 6 (CK6) in McF-7 Breast Cancer Cells

PLoS ONE
Multidisciplinary
2015English

Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated With Tamoxifen

Frontiers in Pharmacology
Pharmacology
2017English

Genotyping of the UDP-Glucuronosyltransferase (UGT) 1A7 Gene Revisited

Gastroenterology
HepatologyGastroenterology
2011English

Pcn191 - Cost-Effectiveness of Monitoring Endoxifen Levels in Breast Cancer Patients Adjuvantly Treated With Tamoxifen

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Effect of Retinoids on UDP-Glucuronosyltransferase 2B7 mRNA Expression in Caco-2 Cells

Drug Metabolism and Pharmacokinetics
PharmacologyPharmaceutical Science
2008English

Rapamycin Enhances the Sensitivity of ER‑positive Breast Cancer Cells to Tamoxifen by Upregulating P73 Expression

Oncology Reports
MedicineCancer ResearchOncology
2018English

UDP-Glucuronosyltransferase 1a Enzymes Are Present and Active in the Mouse Blastocyst

Drug Metabolism and Disposition
PharmacologyPharmaceutical Science
2014English

Ishikawa Cells Exhibit Differential Gene Expression Profiles in Response to Oestradiol or 4-Hydroxytamoxifen

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2007English

Functional Polymorphisms in UDP-Glucuronosyl Transferases and Recurrence in Tamoxifen-Treated Breast Cancer Survivors

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy